613 related articles for article (PubMed ID: 33534581)
21. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
[TBL] [Abstract][Full Text] [Related]
22. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
Thygesen C; Metaxas A; Larsen MR; Finsen B
J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
[TBL] [Abstract][Full Text] [Related]
23. CD8
Unger MS; Li E; Scharnagl L; Poupardin R; Altendorfer B; Mrowetz H; Hutter-Paier B; Weiger TM; Heneka MT; Attems J; Aigner L
Brain Behav Immun; 2020 Oct; 89():67-86. PubMed ID: 32479993
[TBL] [Abstract][Full Text] [Related]
24. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
25. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
26. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.
Wang SS; Jia J; Wang Z
J Alzheimers Dis; 2018; 61(3):1005-1013. PubMed ID: 29254100
[TBL] [Abstract][Full Text] [Related]
28. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice.
Quan W; Luo Q; Hao W; Tomic I; Furihata T; Schulz-Schäffer W; Menger MD; Fassbender K; Liu Y
Glia; 2021 Aug; 69(8):1987-2005. PubMed ID: 33934399
[TBL] [Abstract][Full Text] [Related]
29. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
30. APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints.
Yin Z; Rosenzweig N; Kleemann KL; Zhang X; Brandão W; Margeta MA; Schroeder C; Sivanathan KN; Silveira S; Gauthier C; Mallah D; Pitts KM; Durao A; Herron S; Shorey H; Cheng Y; Barry JL; Krishnan RK; Wakelin S; Rhee J; Yung A; Aronchik M; Wang C; Jain N; Bao X; Gerrits E; Brouwer N; Deik A; Tenen DG; Ikezu T; Santander NG; McKinsey GL; Baufeld C; Sheppard D; Krasemann S; Nowarski R; Eggen BJL; Clish C; Tanzi RE; Madore C; Arnold TD; Holtzman DM; Butovsky O
Nat Immunol; 2023 Nov; 24(11):1839-1853. PubMed ID: 37749326
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-β oligomerizes.
Pérez-González R; Kim Y; Miller C; Pacheco-Quinto J; Eckman EA; Levy E
FASEB J; 2020 Sep; 34(9):12922-12931. PubMed ID: 32772431
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
[TBL] [Abstract][Full Text] [Related]
33. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
34. The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
von Linstow CU; Waider J; Bergh MS; Anzalone M; Madsen C; Nicolau AB; Wirenfeldt M; Lesch KP; Finsen B
J Alzheimers Dis; 2022; 85(3):1283-1300. PubMed ID: 34924373
[TBL] [Abstract][Full Text] [Related]
35. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease.
He K; Nie L; Zhou Q; Rahman SU; Liu J; Yang X; Li S
J Proteome Res; 2019 Jun; 18(6):2632-2642. PubMed ID: 31055927
[TBL] [Abstract][Full Text] [Related]
37. Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice.
Manocha GD; Floden AM; Miller NM; Smith AJ; Nagamoto-Combs K; Saito T; Saido TC; Combs CK
Neurobiol Aging; 2019 Sep; 81():166-176. PubMed ID: 31284126
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
[TBL] [Abstract][Full Text] [Related]
39. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice.
Kwon H; Lee EH; Park SY; Park JY; Hong JH; Kim EK; Shin TS; Kim YK; Han PL
Exp Mol Med; 2023 Sep; 55(9):2067-2082. PubMed ID: 37704750
[TBL] [Abstract][Full Text] [Related]
40. Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
Chintapaludi SR; Uyar A; Jackson HM; Acklin CJ; Wang X; Sasner M; Carter GW; Howell GR
J Alzheimers Dis; 2020; 73(4):1421-1434. PubMed ID: 31929156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]